Help Your Self-Insured Clients Reduce Diagnostic Waste and Improve Outcomes

Deliver 8-10 % outpatient lab savings with evidence-based diagnostic intelligence — implemented through carriers and TPAs, with no disruption to employers.

Avalon transforms lab testing from a hidden cost driver into a managed, evidence-based asset — enabling brokers and consultants to deliver measurable savings, stronger clinical alignment, and differentiated employer value through existing carrier and TPA partners.

Schedule a Meeting to Hear the Broker Value Story

Why Employers Are Asking for More

Rising outpatient lab and hospital-based testing costs

Oncology and GLP-1 spend driven by inconsistent diagnostic decision-making

Employee dissatisfaction tied to unnecessary testing and out-of-pocket costs

Up to 30% of routine lab testing is unnecessary, and for every $1 spent on low-value diagnostics, $2-$6 in downstream costs often follow.

Brokers and consultants are now expected to bring actionable solutions, not just visibility.

Explore Where Diagnostic Waste Shows Up

The Avalon Broker Advantage

What You Can Confidently Take to Employers

All delivered via existing carrier or TPA partners — preserving relationships and minimizing friction.

8-10 % reduction in outpatient routine lab spend
$1–$3 PMPM impact across self-insured populations
~25% reduction in employee out-of-pocket costs
Renewal-ready analytics brokers can present directly to clients

Diagnostic Intelligence That Elevates Advisory Value

Avalon transforms lab claims into diagnostic intelligence, enabling brokers to:

Support personalized, value-based care

Improve testing accuracy (right test, right time)

Reduce under- and over-utilization

Strengthen employer confidence in benefits decisions

Evidence-Based Science You Can Trust

Avalon’s platform is grounded in independent diagnostic science:

65+ evidence-based routine lab policies

Independent Clinical Advisory Board (MDs & PhDs)

20,000+ lab tests governed by clinical rigor

10+ years of validated diagnostic waste reduction

This ensures employers receive appropriate care without unnecessary testing — and advisors bring defensible recommendations.

Employer-Relevant Use Cases Brokers Can Lead With

These use cases help employers connect clinical decisions to financial performance — a growing expectation in advisory relationships.

Personalized & Value-Based Care

Use diagnostic insights to align testing and treatment, supporting better outcomes and lower total cost of care.

Oncology Drug & Diagnostic Management

Ensure appropriate genetic and molecular testing informs therapy selection — reducing avoidable drug spend and improving treatment accuracy.

GLP-1 Investment Optimization

Support equitable, evidence-aligned GLP-1 access using lab-driven risk stratification rather than blunt BMI-only policies.

Watch our latest webinar on this topic – Diagnostic Waste in Plain Sight: Turning Lab Overutilization into Measurable Employer Savings & Impact – that walks through where the savings opportunities are and how they’re being captured in practice.

Give Employers a Diagnostic Strategy — Not Just Another Report

Schedule a 15-Minute Broker Overview